Menu Close

COVID Coag: A Conversation about the Controversies and Confusion

September 15, 2020

Guest speaker Andrew J. Goodwin, MD, Division Chief for Clinical Laboratory Medicine and the CLIA Medical Director for University of Vermont Medical Center Laboratories discusses the connection between SARS-CoV2/COVID-19, coagulopathy and the unique nature of hemostasis in COVID-19 patients.

Click here to watch the webinar “COVID Coag: A Conversation about the Controversies and Confusion” sponsored by BioMedica Diagnostics.

Related